Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
Burgy M, Jehl A, Conrad O, Foppolo S, Bruban V, Etienne-Selloum N, Jung AC, Masson M, Macabre C, Ledrappier S, Burckel H, Mura C, Noël G, Borel C, Fasquelle F, Onea MA, Chenard MP, Thiéry A, Dontenwill M, Martin S. Burgy M, et al. Among authors: dontenwill m. Cancers (Basel). 2021 Jun 18;13(12):3038. doi: 10.3390/cancers13123038. Cancers (Basel). 2021. PMID: 34207120 Free PMC article.
Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist.
Martin S, Cosset EC, Terrand J, Maglott A, Takeda K, Dontenwill M. Martin S, et al. Among authors: dontenwill m. Biochim Biophys Acta. 2009 Feb;1793(2):354-67. doi: 10.1016/j.bbamcr.2008.09.019. Epub 2008 Oct 17. Biochim Biophys Acta. 2009. PMID: 18992284 Free article.
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.
Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S. Jung AC, et al. Among authors: dontenwill m. Oncotarget. 2015 Dec 8;6(39):41884-901. doi: 10.18632/oncotarget.6099. Oncotarget. 2015. PMID: 26474461 Free PMC article.
Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
Sani S, Messe M, Fuchs Q, Pierrevelcin M, Laquerriere P, Entz-Werle N, Reita D, Etienne-Selloum N, Bruban V, Choulier L, Martin S, Dontenwill M. Sani S, et al. Among authors: dontenwill m. Chembiochem. 2021 Apr 6;22(7):1151-1160. doi: 10.1002/cbic.202000626. Epub 2020 Nov 27. Chembiochem. 2021. PMID: 33140906 Review.
Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
Blandin AF, Cruz Da Silva E, Mercier MC, Glushonkov O, Didier P, Dedieu S, Schneider C, Devy J, Etienne-Selloum N, Dontenwill M, Choulier L, Lehmann M. Blandin AF, et al. Among authors: dontenwill m. Cell Mol Life Sci. 2021 Mar;78(6):2949-2962. doi: 10.1007/s00018-020-03686-6. Epub 2020 Nov 5. Cell Mol Life Sci. 2021. PMID: 33151388 Free PMC article.
119 results